Cube Pharmaceuticals announced that it recently received the “Notice of Approval of the Marketing Application for Chemical Ingredient” for dextrophenide hydrochloride issued by the State Drug Administration. The application for domestic production and marketing of the API was approved. The registration number is Y20240001340. The notice is valid until September 19, 2031.

Cube Pharmaceuticals announced that it recently received the “Notice of Approval of the Marketing Application for Chemical Ingredient” for dextrophenide hydrochloride issued by the State Drug Administration. The application for domestic production and marketing of the API was approved. The registration number is Y20240001340. The notice is valid until September 19, 2031.